aKRAS
/ Oblique Therap
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 26, 2021
"Oblique Therapeutics announces achievement of key milestone in its aKRAS-mAb program and Abiprot® platform https://t.co/FvOrUanSTH"
(@CisionNews)
1 to 1
Of
1
Go to page
1